Artivion, Inc. (AORT)
NYSE: AORT · Real-Time Price · USD
26.31
-0.81 (-2.99%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Artivion Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 471.47 | 441.33 | 388.54 | 354 | 313.79 | 298.84 |
Revenue Growth | 16.40% | 13.59% | 9.75% | 12.82% | 5.00% | 18.01% |
Gross Profit Gross Profit Growth | 303.5 | 284.23 | 248.78 | 229.18 | 202.52 | 197.51 |
Operating Income Operating Income Growth | 20.64 | 33.75 | 38.87 | 5.74 | 6.2 | 8.12 |
Net Income Net Income Growth | -3.17 | 9.77 | -13.36 | -30.69 | -19.19 | -14.83 |
Earnings Per Share EPS Growth | -0.07 | 0.21 | -0.32 | -0.75 | -0.48 | -0.38 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Devices Medical Devices Growth | 370.93 | 345.83 | 290.23 | 261.19 | 230.35 | 221.6 |
Preservation Services Preservation Services Growth | 100.54 | 95.51 | 98.31 | 92.82 | 83.44 | 77.24 |
Total Total Growth | 471.47 | 441.33 | 388.54 | 354 | 313.79 | 298.84 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 77.32 | 64.91 | 53.46 | 58.94 | 39.35 | 55.01 |
Total Debt Total Debt Growth | 407.97 | 257.61 | 362.26 | 358.34 | 356.83 | 362.04 |
Net Cash (Debt) Net Cash Growth | -330.65 | -192.71 | -308.8 | -299.4 | -317.48 | -307.03 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -6.73 | -4.09 | -7.41 | -7.35 | -7.93 | -7.88 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 41.71 | 39.88 | 22.24 | 18.83 | -5.15 | -2.59 |
Capital Expenditures CapEx Growth | -50.87 | -39.04 | -11.19 | -9.75 | -10.72 | -13.09 |
Free Cash Flow Free Cash Flow Growth | -9.16 | 0.84 | 11.05 | 9.07 | -15.87 | -15.68 |
Free Cash Flow Growth | - | -92.41% | 21.77% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 64.37% | 64.40% | 64.03% | 64.74% | 64.54% | 66.09% |
Operating Margin | 4.38% | 7.65% | 10.01% | 1.62% | 1.98% | 2.72% |
Pretax Margin | 0.47% | 3.35% | -1.93% | -6.10% | -4.78% | -4.96% |
Profit Margin | -0.67% | 2.21% | -3.44% | -8.67% | -6.12% | -4.96% |
FCF Margin | -1.94% | 0.19% | 2.84% | 2.56% | -5.06% | -5.25% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 217.19 | - | - | - | - |
Forward PE | 249.62 | 127.40 | 280.54 | 262.49 | 262.49 | 106.05 |
P/FCF Ratio | - | 2600.86 | 108.55 | 80.96 | - | - |
PS Ratio | 2.72 | 4.94 | 3.09 | 2.07 | 1.56 | 2.72 |